Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15484320 | 0.96 | CYP3A4 (0.35) | CYP3A4TDP1KCNN4TP53TAAR1 | |
| SCHEMBL662184 | 0.89 | CYP3A4 (0.39) | CYP3A4TDP1KCNN4TP53TAAR1 | |
| SCHEMBL18214942 | 0.86 | CYP3A4 (0.38) | CYP3A4TDP1KCNN4TAAR1SLC6A2 | |
| SCHEMBL11681580 | 0.86 | CYP3A4 (0.38) | CYP3A4TDP1KCNN4TAAR1SLC6A2 | |
| SCHEMBL16859262 | 0.86 | CYP3A4 (0.38) | CYP3A4TDP1KCNN4TAAR1SLC6A2 | |
| Hydrochloric Acid SCHEMBL1450177 | 0.86 | TDP1 (0.38) | CYP3A4TDP1KCNN4TAAR1SLC6A2 | |
| SCHEMBL1559777 | 0.85 | TSHR (0.31) | ESR1ESR2 | |
| SCHEMBL27851234 | 0.83 | KCNN4 (0.32) | CYP3A4TDP1KCNN4TP53 | |
| SCHEMBL15485017 | 0.83 | KCNN4 (0.32) | CYP3A4TDP1KCNN4TP53 | |
| SCHEMBL28791530 | 0.83 | CYP3A4 (0.35) | CYP3A4TDP1KCNN4TP53TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2024-02-27 | — | — | US | disclosed |
| US-9650310-B2 | Method for the methylation of nitrogen-containing organic compounds | RHEINISCHE-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN (DE) | 2017-05-16 | — | — | US | disclosed |
| US-20160168043-A1 | METHOD FOR THE METHYLATION OF NITROGEN-CONTAINING ORGANIC COMPOUNDS | RHEINISCHE-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN (DE) | 2016-06-16 | — | — | US | disclosed |
| US-9216933-B2 | Reduction method for the reduction of carbon dioxide and carbon dioxide derivatives | RHEINISCH-WESTFALISCHE TECHNISCHE HOCHSCHULE AACHEN (DE) | 2015-12-22 | — | — | US | disclosed |
| US-20150087867-A1 | REDUCTION METHOD FOR THE REDUCTION OF CARBON DIOXIDE AND CARBON DIOXIDE DERIVATIVES | RHEINISCH-WESTFALISCHE TECHNISCHE HOCHSCHULE AACHEN (DE) | 2015-03-26 | — | — | US | disclosed |
| WO-2000009584-A1 | CATALYST COMPOSITION AND PROCESS FOR THE PREPARATION OF COPOLYMERS OF CARBON MONOXIDE AND AN OLEFINICALLY UNSATURATED COMPOUND | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2000-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087867-A1 | REDUCTION METHOD FOR THE REDUCTION OF CARBON DIOXIDE AND CARBON DIOXIDE DERIVATIVES | MT-CO2, SCO2, CBR3 | CYP3A4 207/4885TDP1 4356/4885KCNN4 1871/4885 |
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | PFAS, EPM2A, CYP2F1 | CYP3A4 68/4885TDP1 2945/4885KCNN4 1467/4885 |
| US-20160168043-A1 | METHOD FOR THE METHYLATION OF NITROGEN-CONTAINING ORGANIC COMPOUNDS | HNMT, PNMT, GNMT | CYP3A4 374/4885TDP1 1954/4885KCNN4 1187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.